65,437 trials
Cervical Cancer
Primary: Cohort 1: Objective Response Rate (ORR) Assessed by an Independent Review Committee (IRC) in PD-L1-Positive Participants — 26.2 percentage of participants — p=0.0054
Spinal Cord Injuries
Primary: Brief Pain Inventory, Worst Pain — 8.9; 9.7 score on scale
Stroke · Aphasia
Primary: Mean Scores on the Client Satisfaction Questionnaire - 8 — 29.7 score on a scale
Aesthetic Dermatology
Primary: Performance — 97.6 percentage of participants
Glottic Carcinoma
Primary: Number of Patients With Local Failure Following SABR Treatment of Early Glottic Larynx Cancers — 2 participants
Stoma Ileostomy
Primary: Peel Force — 5.2; 3; 2.1; 3.3 Newton
HIV
Primary: Change in Proportion of Missed Antiretroviral (ARV) Doses From Baseline Among Clients — 90.14; 91.68; 95.64; 96.73 percentage of total missed ARV doses — p=0.38
Dementia · Cognitive Impairment
Primary: Person With Dementia: Oral Hygiene — 29.6; 37.3 percentage change in plaque scores
Influenza Virus Infection Transmission in Humans
Primary: Viral Copy Number in 30-minute Exhaled Breath Sample — 38,000; 12,000 Fine aerosol RNA copy number
Hyperammonemia
Primary: Safety of TNP-2092 by Assessment of the Number of Participants With Adverse Events (AEs) — 0; 1; 2; 1 Participants
Chronic Diabetic Foot Ulcers · Diabetic Neuropathic Ulcers · Non Healing Wound
Primary: Percentage of Complete Wound Closure, as Assessed Over a 12 Week Period — 8; 7 Participants
Spinal Cord Injuries · Hand Weakness
Primary: Percent Change in Time to Achieve Secure Grasp (Cognition Glove Only) — 39.9; -14.6; 10.1 % change in time to secure grasp
Cardiac Arrest
Primary: Successful Conversion to an Organized Heart Rhythm — 28; 39 Participants
Myotonic Dystrophy 1 · Excessive Daytime Sleepiness
Primary: Change in Excessive Daytime Sleepiness (EDS) Based on Change in Daytime Sleepiness Scale (DSS) Score — -3.8; -1.8; 0.0 score on a scale
PTSD
Primary: Clinician Assessed Severity of PTSD — 41.74; 43.06; 27.78; 34.00 score on a scale